Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
March 18, 2025 16:05 ET
|
OncoCyte Corporation
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 11, 2025 08:30 ET
|
OncoCyte Corporation
Oncocyte to Participate in BTIG MedTech, Digital Health,
Life Science & Diagnostic Tools Conference
Oncocyte Prices $29.1 Million Equity Offering
February 10, 2025 08:30 ET
|
OncoCyte Corporation
Oncocyte Prices $29.1 Million Equity Offering
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
January 08, 2025 08:30 ET
|
OncoCyte Corporation
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
January 06, 2025 16:05 ET
|
OncoCyte Corporation
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings
December 09, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings – January 13-16, 2025, San Francisco, CA
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
December 04, 2024 16:15 ET
|
OncoCyte Corporation
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms
December 02, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with Oncocyte’s assay significantly reduces time to...
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
November 12, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
November 06, 2024 16:45 ET
|
OncoCyte Corporation
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12